|Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma||
||46||All||1 Year to 30 Years (Child, Adult)||NCT01614795||NCI-2012-01971
|June 18, 2012||April 1, 2014||April 1, 2014||June 8, 2012||December 11, 2018||March 31, 2015||
|2||NCT00720174||Completed||Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma||
||30||All||16 Years and older (Child, Adult, Older Adult)||NCT00720174||NCI-2009-00285
|June 2008||January 2013||July 22, 2008||May 17, 2016||
† Study has passed its completion date and status has not been verified in more than two years.